Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Edward Cone
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Chemicals & Drugs
Disorders
Anatomy
Activities & Behaviors
Concepts & Ideas
Living Beings
Sign-in to see full Profile
Network (preview)
35
Huestis, Marilyn
33
Darwin, William
17
Preston, Kenzie
15
Goldberger, Bruce
15
Henningfield, Jack
13
Oyler, Jonathan
12
Joseph, Robert
11
Moolchan, Eric
10
Caplan, Yale
9
Jufer, Rebecca
9
Su, Tsung-Ping
6
Silverman, Kenneth
6
Vaupel, Bruce
6
Barnes, Allan
5
Fritch, Dean
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Edward Cone (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Cone Edward J; Caplan Yale H
Urine toxicology testing in chronic pain management.
Postgraduate medicine 2009;121(4):91-102.
-
2009: Black David L; Cawthon Beverly; Robert Tim; Moser Frank; Caplan Yale H; Cone Edward J
Multiple drug ingestion by ecstasy abusers in the United States.
Journal of analytical toxicology 2009;33(3):143-7.
-
2009: Cone Edward J; Caplan Yale H; Moser Frank; Robert Tim; Shelby Melinda K; Black David L
Normalization of urinary drug concentrations with specific gravity and creatinine.
Journal of analytical toxicology 2009;33(1):1-7.
-
2009: Shiffman Saul; Cone Edward J; Buchhalter August R; Henningfield Jack E; Rohay Jeffrey M; Gitchell Joe G; Pinney John M; Chau Tommy
Rapid absorption of nicotine from new nicotine gum formulations.
Pharmacology, biochemistry, and behavior 2009;91(3):380-4.
-
2008: Chin Jenna M; Merves Michele L; Goldberger Bruce A; Sampson-Cone Angela; Cone Edward J
Caffeine content of brewed teas.
Journal of analytical toxicology 2008;32(8):702-4.
-
2008: Cone Edward J; Caplan Yale H; Black David L; Robert Timothy; Moser Frank
Urine drug testing of chronic pain patients: licit and illicit drug patterns.
Journal of analytical toxicology 2008;32(8):530-43.
-
2008: Jenkins Amanda J; Cone Edward J
Time of heroin use.
Journal of analytical toxicology 2008;32(6):454-6.
-
2008: Cone Edward J; Caplan Yale H; Moser Frank; Robert Tim; Black David
Evidence that morphine is metabolized to hydromorphone but not to oxymorphone.
Journal of analytical toxicology 2008;32(4):319-23.
-
2008: Barnes Allan J; Smith Michael L; Kacinko Sherri L; Schwilke Eugene W; Cone Edward J; Moolchan Eric T; Huestis Marilyn A
Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration.
Clinical chemistry 2008;54(1):172-80.
-
2007: Huestis Marilyn A; Darwin W David; Shimomura Eric; Lalani Shairose A; Trinidad Daniel V; Jenkins Amanda J; Cone Edward J; Jacobs Aaron J; Smith Michael L; Paul Buddha D
Cocaine and metabolites urinary excretion after controlled smoked administration.
Journal of analytical toxicology 2007;31(8):462-8.
-
2007: Cone Edward J; Clarke Joe; Tsanaclis Lolita
Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.
Journal of analytical toxicology 2007;31(8):424-33.
-
2007: Huestis Marilyn A; Cone Edward J
Methamphetamine disposition in oral fluid, plasma, and urine.
Annals of the New York Academy of Sciences 2007;1098():104-21.
-
2007: Cone Edward J; Huestis Marilyn A
Interpretation of oral fluid tests for drugs of abuse.
Annals of the New York Academy of Sciences 2007;1098():51-103.
-
2006: McCusker Rachel R; Fuehrlein Brian; Goldberger Bruce A; Gold Mark S; Cone Edward J
Caffeine content of decaffeinated coffee.
Journal of analytical toxicology 2006;30(8):611-3.
-
2006: Kolbrich Erin A; Barnes Allan J; Gorelick David A; Boyd Susan J; Cone Edward J; Huestis Marilyn A
Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration.
Journal of analytical toxicology 2006;30(8):501-10.
-
2006: Jufer Rebecca; Walsh Sharon L; Cone Edward J; Sampson-Cone Angela
Effect of repeated cocaine administration on detection times in oral fluid and urine.
Journal of analytical toxicology 2006;30(7):458-62.
-
2006: Schwilke Eugene W; Barnes Allan J; Kacinko Sherri L; Cone Edward J; Moolchan Eric T; Huestis Marilyn A
Opioid disposition in human sweat after controlled oral codeine administration.
Clinical chemistry 2006;52(8):1539-45.
-
2006: Cone Edward J
Ephemeral profiles of prescription drug and formulation tampering: evolving pseudoscience on the Internet.
Drug and alcohol dependence 2006;83 Suppl 1():S31-9.
-
2006: Cone Edward J
Oral fluid testing: new technology enables drug testing without embarrassment.
Journal of the California Dental Association 2006;34(4):311-5.
-
2006: Yang Wonkyung; Barnes Allan J; Ripple Mary G; Fowler David R; Cone Edward J; Moolchan Eric T; Chung Heesun; Huestis Marilyn A
Simultaneous quantification of methamphetamine, cocaine, codeine, and metabolites in skin by positive chemical ionization gas chromatography-mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2006;833(2):210-8.
-
2006: McCusker Rachel R; Goldberger Bruce A; Cone Edward J
Caffeine content of energy drinks, carbonated sodas, and other beverages.
Journal of analytical toxicology 2006;30(2):112-4.
-
2006: Cone Edward J; Heit Howard A; Caplan Yale H; Gourlay Douglas
Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine.
Journal of analytical toxicology 2006;30(1):1-5.
-
2005: Kacinko Sherri L; Barnes Allan J; Schwilke Eugene W; Cone Edward J; Moolchan Eric T; Huestis Marilyn A
Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration.
Clinical chemistry 2005;51(11):2085-94.
-
2005: Niedbala R Sam; Kardos Keith W; Fritch Dean F; Kunsman Kenneth P; Blum Kristen A; Newland Gregory A; Waga Joe; Kurtz Lisa; Bronsgeest Matth; Cone Edward J
Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
Journal of analytical toxicology 2005;29(7):607-15.
-
2005: Carmona Gilberto N; Schindler Charles W; Greig Nigel H; Holloway Harold W; Jufer Rebecca A; Cone Edward J; Gorelick David A
Intravenous butyrylcholinesterase administration and plasma and brain levels of cocaine and metabolites in rats.
European journal of pharmacology 2005;517(3):186-90.
-
2005: Jenkins Amanda J; Henningfield Jack E; Cone Edward J
Relationship between plasma and oral fluid nicotine concentrations in humans: a pilot study.
Therapeutic drug monitoring 2005;27(3):345-8.
-
2005: Scheidweiler Karl B; Cone Edward J; Moolchan Eric T; Huestis Marilyn A
Dose-related distribution of codeine, cocaine, and metabolites into human hair following controlled oral codeine and subcutaneous cocaine administration.
The Journal of pharmacology and experimental therapeutics 2005;313(2):909-15.
-
2004: Kim Insook; Oyler Jonathan M; Moolchan Eric T; Cone Edward J; Huestis Marilyn A
Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans.
Therapeutic drug monitoring 2004;26(6):664-72.
-
2004: Cone Edward J; Fant Reginald V; Rohay Jeffrey M; Caplan Yale H; Ballina Mayra; Reder Robert F; Haddox J David
Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions.
Journal of analytical toxicology 2004;28(7):616-24.
-
2004: Niedbala Sam; Kardos Keith; Salamone Sal; Fritch Dean; Bronsgeest Matth; Cone Edward J
Passive cannabis smoke exposure and oral fluid testing.
Journal of analytical toxicology 2004;28(7):546-52.
-
2004: Umbricht Annie; Huestis Marilyn A; Cone Edward J; Preston Kenzie L
Effects of high-dose intravenous buprenorphine in experienced opioid abusers.
Journal of clinical psychopharmacology 2004;24(5):479-87.
-
2004: Huestis Marilyn A; Cone Edward J
Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
Journal of analytical toxicology 2004;28(6):394-9.
-
2004: Cone Edward J; Fant Reginald V; Rohay Jeffrey M; Caplan Yale H; Ballina Mayra; Reder Robert F; Haddox J David
Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions.
Journal of analytical toxicology 2004;28(4):217-25.
-
2003: McCusker Rachel R; Goldberger Bruce A; Cone Edward J
Caffeine content of specialty coffees.
Journal of analytical toxicology 2003;27(7):520-2.
-
2003: Cone Edward J; Sampson-Cone Angela H; Darwin William D; Huestis Marilyn A; Oyler Jonathan M
Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results.
Journal of analytical toxicology 2003;27(7):386-401.
-
2003: Presley Lance; Lehrer Michael; Seiter William; Hahn Dawn; Rowland Barbara; Smith Melissa; Kardos Keith W; Fritch Dean; Salamone Sal; Niedbala R Sam; Cone Edward J
High prevalence of 6-acetylmorphine in morphine-positive oral fluid specimens.
Forensic science international 2003;133(1-2):22-5.
-
2003: Cone Edward J; Fant Reginald V; Rohay Jeffrey M; Caplan Yale H; Ballina Mayra; Reder Robert F; Spyker Daniel; Haddox J David
Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases.
Journal of analytical toxicology 2003;27(2):57-67; discussion 67.
-
2003: Schepers Raf J F; Oyler Jonathan M; Joseph Robert E; Cone Edward J; Moolchan Eric T; Huestis Marilyn A
Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers.
Clinical chemistry 2003;49(1):121-32.
-
2002: Cone Edward J; Presley Lance; Lehrer Michael; Seiter William; Smith Melissa; Kardos Keith W; Fritch Dean; Salamone Sal; Niedbala R Sam
Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations.
Journal of analytical toxicology 2002;26(8):541-6.
-
2002: Preston Kenzie L; Epstein David H; Cone Edward J; Wtsadik Abraham T; Huestis Marilyn A; Moolchan Eric T
Urinary elimination of cocaine metabolites in chronic cocaine users during cessation.
Journal of analytical toxicology 2002;26(7):393-400.
-
2002: Jenkins Amanda J; Keenan Robert M; Henningfield Jack E; Cone Edward J
Correlation between pharmacological effects and plasma cocaine concentrations after smoked administration.
Journal of analytical toxicology 2002;26(7):382-92.
-
2002: Oyler Jonathan M; Cone Edward J; Joseph Robert E; Moolchan Eric T; Huestis Marilyn A
Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans.
Clinical chemistry 2002;48(10):1703-14.
-
2002: Kim Insook; Barnes Allan J; Oyler Jonathan M; Schepers Raf; Joseph Robert E; Cone Edward J; Lafko Diana; Moolchan Eric T; Huestis Marilyn A
Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration.
Clinical chemistry 2002;48(9):1486-96.
-
2002: Cone Edward J; Preston Kenzie L
Toxicologic aspects of heroin substitution treatment.
Therapeutic drug monitoring 2002;24(2):193-8.
-
2001: Smith M L; Shimomura E T; Summers J; Paul B D; Jenkins A J; Darwin W D; Cone E J
Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin.
Journal of analytical toxicology 2001;25(7):504-14.
-
2001: Cone E J
Legal, workplace, and treatment drug testing with alternate biological matrices on a global scale.
Forensic science international 2001;121(1-2):7-15.
-
2001: Niedbala R S; Kardos K W; Fritch D F; Kardos S; Fries T; Waga J; Robb J; Cone E J
Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.
Journal of analytical toxicology 2001;25(5):289-303.
-
2001: Johnson R E; Jones H E; Jasinski D R; Svikis D S; Haug N A; Jansson L M; Kissin W B; Alpan G; Lantz M E; Cone E J; Wilkins D G; Golden A S; Huggins G R; Lester B M
Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes.
Drug and alcohol dependence 2001;63(1):97-103.
-
2000: Oyler J M; Cone E J; Joseph R E; Huestis M A
Identification of hydrocodone in human urine following controlled codeine administration.
Journal of analytical toxicology 2000;24(7):530-5.
-
2000: Smith M L; Shimomura E T; Summers J; Paul B D; Nichols D; Shippee R; Jenkins A J; Darwin W D; Cone E J
Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration.
Journal of analytical toxicology 2000;24(7):522-9.
-
2000: Huestis M A; Cone E J; Wong C J; Umbricht A; Preston K L
Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
Journal of analytical toxicology 2000;24(7):509-21.
-
2000: Ropero-Miller J D; Goldberger B A; Cone E J; Joseph R E
The disposition of cocaine and opiate analytes in hair and fingernails of humans following cocaine and codeine administration.
Journal of analytical toxicology 2000;24(7):496-508.
-
2000: Jufer R A; Wstadik A; Walsh S L; Levine B S; Cone E J
Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers.
Journal of analytical toxicology 2000;24(7):467-77.
-
2000: Moolchan E T; Cone E J; Wstadik A; Huestis M A; Preston K L
Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: plasma and saliva analysis.
Journal of analytical toxicology 2000;24(7):458-66.
-
2000: Carmona G N; Jufer R A; Goldberg S R; Gorelick D A; Greig N H; Yu Q S; Cone E J; Schindler C W
Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans.
Drug metabolism and disposition: the biological fate of chemicals 2000;28(3):367-71.
-
2000: Robles E; Silverman K; Preston K L; Cone E J; Katz E; Bigelow G E; Stitzer M L
The brief abstinence test: voucher-based reinforcement of cocaine abstinence.
Drug and alcohol dependence 2000;58(1-2):205-12.
-
1999: Huestis M A; Oyler J M; Cone E J; Wstadik A T; Schoendorfer D; Joseph R E
Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications 1999;733(1-2):247-64.
-
1999: Wilkins D G; Rollins D E; Valdez A S; Mizuno A; Krueger G G; Cone E J
A retrospective study of buprenorphine and norbuprenorphine in human hair after multiple doses.
Journal of analytical toxicology 1999;23(6):409-15.
-
1999: Joseph R E; Höld K M; Wilkins D G; Rollins D E; Cone E J
Drug testing with alternative matrices II. Mechanisms of cocaine and codeine deposition in hair.
Journal of analytical toxicology 1999;23(6):396-408.
-
1999: Preston K L; Huestis M A; Wong C J; Umbricht A; Goldberger B A; Cone E J
Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing.
Journal of analytical toxicology 1999;23(5):313-22.
-
1999: LeBeau M; Andollo W; Hearn W L; Baselt R; Cone E; Finkle B; Fraser D; Jenkins A; Mayer J; Negrusz A; Poklis A; Walls H C; Raymon L; Robertson M; Saady J
Recommendations for toxicological investigations of drug-facilitated sexual assaults.
Journal of forensic sciences 1999;44(1):227-30.
-
1998: Cone E J
Recent discoveries in pharmacokinetics of drugs of abuse.
Toxicology letters 1998;102-103():97-101.
-
1998: Preston K L; Goldberger B A; Cone E J
Occurrence of cocaine in urine of substance-abuse treatment patients.
Journal of analytical toxicology 1998;22(7):580-6.
-
1998: Goldberger B A; Darraj A G; Caplan Y H; Cone E J
Detection of methadone, methadone metabolites, and other illicit drugs of abuse in hair of methadone-treatment subjects.
Journal of analytical toxicology 1998;22(6):526-30.
-
1998: Cone E J; Lange R; Darwin W D
In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test results.
Journal of analytical toxicology 1998;22(6):460-73.
-
1998: Huestis M A; Cone E J
Differentiating new marijuana use from residual drug excretion in occasional marijuana users.
Journal of analytical toxicology 1998;22(6):445-54.
-
1998: Jufer R A; Walsh S L; Cone E J
Cocaine and metabolite concentrations in plasma during repeated oral administration: development of a human laboratory model of chronic cocaine use.
Journal of analytical toxicology 1998;22(6):435-44.
-
1998: Huestis M A; Cone E J
Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans.
Therapeutic drug monitoring 1998;20(5):570-6.
-
1998: Cone E J; Tsadik A; Oyler J; Darwin W D
Cocaine metabolism and urinary excretion after different routes of administration.
Therapeutic drug monitoring 1998;20(5):556-60.
-
1998: Preston K L; Silverman K; Higgins S T; Brooner R K; Montoya I; Schuster C R; Cone E J
Cocaine use early in treatment predicts outcome in a behavioral treatment program.
Journal of consulting and clinical psychology 1998;66(4):691-6.
-
1998: Carmona G N; Schindler C W; Shoaib M; Jufer R; Cone E J; Goldberg S R; Greig N H; Yu Q S; Gorelick D A
Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase.
Experimental and clinical psychopharmacology 1998;6(3):274-9.
-
1998: Panlilio L V; Goldberg S R; Gilman J P; Jufer R; Cone E J; Schindler C W
Effects of delivery rate and non-contingent infusion of cocaine on cocaine self-administration in rhesus monkeys.
Psychopharmacology 1998;137(3):253-8.
-
1998: Kuhlman J J; Levine B; Johnson R E; Fudala P J; Cone E J
Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine.
Addiction (Abingdon, England) 1998;93(4):549-59.
-
1998: Walsh S L; Johnson R E; Cone E J; Bigelow G E
Intravenous and oral l-alpha-acetylmethadol: pharmacodynamics and pharmacokinetics in humans.
The Journal of pharmacology and experimental therapeutics 1998;285(1):71-82.
-
1998: Höld K M; Wilkins D G; Rollins D E; Joseph R E; Cone E J
Simultaneous quantitation of cocaine, opiates, and their metabolites in human hair by positive ion chemical ionization gas chromatography-mass spectrometry.
Journal of chromatographic science 1998;36(3):125-30.
-
1998: Joseph R E; Oyler J M; Wstadik A T; Ohuoha C; Cone E J
Drug testing with alternative matrices I. Pharmacological effects and disposition of cocaine and codeine in plasma, sebum, and stratum corneum.
Journal of analytical toxicology 1998;22(1):6-17.
-
1997: Cone E J; Oyler J; Darwin W D
Cocaine disposition in saliva following intravenous, intranasal, and smoked administration.
Journal of analytical toxicology 1997;21(6):465-75.
-
1997: Joseph R E; Tsai W J; Tsao L I; Su T P; Cone E J
In vitro characterization of cocaine binding sites in human hair.
The Journal of pharmacology and experimental therapeutics 1997;282(3):1228-41.
-
1997: Preston K L; Silverman K; Schuster C R; Cone E J
Assessment of cocaine use with quantitative urinalysis and estimation of new uses.
Addiction (Abingdon, England) 1997;92(6):717-27.
-
1997: Garside D; Goldberger B A; Preston K L; Cone E J
Rapid liquid-liquid extraction of cocaine from urine for gas chromatographic-mass spectrometric analysis.
Journal of chromatography. B, Biomedical sciences and applications 1997;692(1):61-5.
-
1997: Skopp G; Ganssmann B; Cone E J; Aderjan R
Plasma concentrations of heroin and morphine-related metabolites after intranasal and intramuscular administration.
Journal of analytical toxicology 1997;21(2):105-11.
-
1997: Preston K L; Silverman K; Schuster C R; Cone E J
Use of quantitative urinalysis in monitoring cocaine use.
NIDA research monograph 1997;175():253-64.
-
1997: Preston K L; Silverman K; Schuster C R; Cone E J
Comparison of self-reported drug use with quantitative and qualitative urinalysis for assessment of drug use in treatment studies.
NIDA research monograph 1997;167():130-45.
-
1997: Cone E J
New developments in biological measures of drug prevalence.
NIDA research monograph 1997;167():108-29.
-
1996: Evans S M; Cone E J; Henningfield J E
Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects.
The Journal of pharmacology and experimental therapeutics 1996;279(3):1345-56.
-
1996: Oyler J; Darwin W D; Preston K L; Suess P; Cone E J
Cocaine disposition in meconium from newborns of cocaine-abusing mothers and urine of adult drug users.
Journal of analytical toxicology 1996;20(6):453-62.
-
1996: Huestis M A; Mitchell J M; Cone E J
Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
Journal of analytical toxicology 1996;20(6):441-52.
-
1996: Cone E J; Jufer R; Darwin W D; Needleman S B
Forensic drug testing for opiates. VII. Urinary excretion profile of intranasal (snorted) heroin.
Journal of analytical toxicology 1996;20(6):379-92.
-
1996: Joseph R E; Su T P; Cone E J
In vitro binding studies of drugs to hair: influence of melanin and lipids on cocaine binding to Caucasoid and Africoid hair.
Journal of analytical toxicology 1996;20(6):338-44.
-
1996: Goldberger B A; Cone E J; Kadehjian L
Unsuspected ethanol ingestion through soft drinks and flavored beverages.
Journal of analytical toxicology 1996;20(5):332-3.
-
1996: Cone E J
Mechanisms of drug incorporation into hair.
Therapeutic drug monitoring 1996;18(4):438-43.
-
1996: Kuhlman J J; Magluilo J; Cone E; Levine B
Simultaneous assay of buprenorphine and norbuprenorphine by negative chemical ionization tandem mass spectrometry.
Journal of analytical toxicology 1996;20(4):229-35.
-
1996: Oyler J; Darwin W D; Cone E J
Cocaine contamination of United States paper currency.
Journal of analytical toxicology 1996;20(4):213-6.
-
1996: Silverman K; Higgins S T; Brooner R K; Montoya I D; Cone E J; Schuster C R; Preston K L
Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy.
Archives of general psychiatry 1996;53(5):409-15.
-
1996: Gygi S P; Joseph R E; Cone E J; Wilkins D G; Rollins D E
Incorporation of codeine and metabolites into hair. Role of pigmentation.
Drug metabolism and disposition: the biological fate of chemicals 1996;24(4):495-501.
-
1996: Cone E J; Kato K; Hillsgrove M
Cocaine excretion in the semen of drug users.
Journal of analytical toxicology 1996;20(2):139-40.
-
1996: Jenkins A J; Llosa T; Montoya I; Cone E J
Identification and quantitation of alkaloids in coca tea.
Forensic science international 1996;77(3):179-89.
-
1996: Carmona G N; Baum I; Schindler C W; Goldberg S R; Jufer R; Cone E; Slaughter E; Belendiuk G W; Gorelick D A
Plasma butyrylcholinesterase activity and cocaine half-life differ significantly in rhesus and squirrel monkeys.
Life sciences 1996;59(11):939-43.
-
1995: Liu R H; Foster G; Cone E J; Kumar S D
Selecting an appropriate isotopic internal standard for gas chromatography/mass spectrometry analysis of drugs of abuse--pentobarbital example.
Journal of forensic sciences 1995;40(6):983-9.
-
1995: Wilkins D; Haughey H; Cone E; Huestis M; Foltz R; Rollins D
Quantitative analysis of THC, 11-OH-THC, and THCCOOH in human hair by negative ion chemical ionization mass spectrometry.
Journal of analytical toxicology 1995;19(6):483-91.
-
1995: Cone E J
Pharmacokinetics and pharmacodynamics of cocaine.
Journal of analytical toxicology 1995;19(6):459-78.
-
1995: Huestis M A; Mitchell J M; Cone E J
Detection times of marijuana metabolites in urine by immunoassay and GC-MS.
Journal of analytical toxicology 1995;19(6):443-9.
-
1995: Cone E J; Yousefnejad D; Hillsgrove M J; Holicky B; Darwin W D
Passive inhalation of cocaine.
Journal of analytical toxicology 1995;19(6):399-411.
-
1995: Jenkins A J; Oyler J M; Cone E J
Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma.
Journal of analytical toxicology 1995;19(6):359-74.
-
1995: June H L; Stitzer M L; Cone E
Acute physical dependence: time course and relation to human plasma morphine concentrations.
Clinical pharmacology and therapeutics 1995;57(3):270-80.
-
1995: Wang W L; Cone E J
Testing human hair for drugs of abuse. IV. Environmental cocaine contamination and washing effects.
Forensic science international 1995;70(1-3):39-51.
-
1995: Goldberger B A; Loewenthal B; Darwin W D; Cone E J
Intrasubject variation of creatinine and specific gravity measurements in consecutive urine specimens of heroin users.
Clinical chemistry 1995;41(1):116-7.
-
1995: Jenkins A J; Darwin W D; Huestis M A; Cone E J; Mitchell J M
Validity testing of the accuPINCH THC test.
Journal of analytical toxicology 1995;19(1):5-12.
-
1995: Joseph R; Dickerson S; Willis R; Frankenfield D; Cone E J; Smith D R
Interference by nonsteroidal anti-inflammatory drugs in EMIT and TDx assays for drugs of abuse.
Journal of analytical toxicology 1995;19(1):13-7.
-
1995: Smith M L; Hughes R O; Levine B; Dickerson S; Darwin W D; Cone E J
Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry.
Journal of analytical toxicology 1995;19(1):18-26.
-
1994: Wang W L; Darwin W D; Cone E J
Simultaneous assay of cocaine, heroin and metabolites in hair, plasma, saliva and urine by gas chromatography-mass spectrometry.
Journal of chromatography. B, Biomedical applications 1994;660(2):279-90.
-
1994: Jenkins A J; Keenan R M; Henningfield J E; Cone E J
Pharmacokinetics and pharmacodynamics of smoked heroin.
Journal of analytical toxicology 1994;18(6):317-30.
-
1994: Cone E J; Hillsgrove M J; Jenkins A J; Keenan R M; Darwin W D
Sweat testing for heroin, cocaine, and metabolites.
Journal of analytical toxicology 1994;18(6):298-305.
-
1994: Goldberger B A; Cone E J
Confirmatory tests for drugs in the workplace by gas chromatography-mass spectrometry.
Journal of chromatography. A 1994;674(1-2):73-86.
-
1994: Cone E J; Hillsgrove M; Darwin W D
Simultaneous measurement of cocaine, cocaethylene, their metabolites, and "crack" pyrolysis products by gas chromatography-mass spectrometry.
Clinical chemistry 1994;40(7 Pt 1):1299-305.
-
1994: Walsh S L; Preston K L; Stitzer M L; Cone E J; Bigelow G E
Clinical pharmacology of buprenorphine: ceiling effects at high doses.
Clinical pharmacology and therapeutics 1994;55(5):569-80.
-
1994: Huestis M A; Mitchell J M; Cone E J
Lowering the federally mandated cannabinoid immunoassay cutoff increases true-positive results.
Clinical chemistry 1994;40(5):729-33.
-
1994: O'Brien T P; Gleason C A; Jones M D; Cone E J; London E D; Traystman R J
Cerebral responses to single and multiple cocaine injections in newborn sheep.
Pediatric research 1994;35(3):339-43.
-
1994: Goldberger B A; Cone E J; Grant T M; Caplan Y H; Levine B S; Smialek J E
Disposition of heroin and its metabolites in heroin-related deaths.
Journal of analytical toxicology 1994;18(1):22-8.
-
1993: Cone E J; Darwin W D; Wang W L
The occurrence of cocaine, heroin and metabolites in hair of drug abusers.
Forensic science international 1993;63(1-3):55-68.
-
1993: Cone E J; Huestis M A
Relating blood concentrations of tetrahydrocannabinol and metabolites to pharmacologic effects and time of marijuana usage.
Therapeutic drug monitoring 1993;15(6):527-32.
-
1993: Kato K; Hillsgrove M; Weinhold L; Gorelick D A; Darwin W D; Cone E J
Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions.
Journal of analytical toxicology 1993;17(6):338-41.
-
1993: Cone E J; Holicky B A; Grant T M; Darwin W D; Goldberger B A
Pharmacokinetics and pharmacodynamics of intranasal "snorted" heroin.
Journal of analytical toxicology 1993;17(6):327-37.
-
1993: Wang W L; Cone E J; Zacny J
Immunoassay evidence for fentanyl in hair of surgery patients.
Forensic science international 1993;61(1):65-72.
-
1993: Cone E J
Saliva testing for drugs of abuse.
Annals of the New York Academy of Sciences 1993;694():91-127.
-
1993: Jenkins A J; Mills L C; Darwin W D; Huestis M A; Cone E J; Mitchell J M
Validity testing of the EZ-SCREEN cannabinoid test.
Journal of analytical toxicology 1993;17(5):292-8.
-
1993: Gleason C A; Iida H; O'Brien T P; Jones M D; Cone E J; Traystman R J
Fetal responses to acute maternal cocaine injection in sheep.
The American journal of physiology 1993;265(1 Pt 2):H9-14.
-
1993: Pickworth W B; Johnson R E; Holicky B A; Cone E J
Subjective and physiologic effects of intravenous buprenorphine in humans.
Clinical pharmacology and therapeutics 1993;53(5):570-6.
-
1993: Cone E J; Huestis M A; Mitchell J M
Do consecutive urine catches differ in marijuana metabolite concentration?
Journal of analytical toxicology 1993;17(3):186-7.
-
1993: Cone E J; Dickerson S; Paul B D; Mitchell J M
Forensic drug testing for opiates. V. Urine testing for heroin, morphine, and codeine with commercial opiate immunoassays.
Journal of analytical toxicology 1993;17(3):156-64.
-
1993: Goldberger B A; Darwin W D; Grant T M; Allen A C; Caplan Y H; Cone E J
Measurement of heroin and its metabolites by isotope-dilution electron-impact mass spectrometry.
Clinical chemistry 1993;39(4):670-5.
-
1992: Cone E J; Darwin W D
Rapid assay of cocaine, opiates and metabolites by gas chromatography-mass spectrometry.
Journal of chromatography 1992;580(1-2):43-61.
-
1992: Huestis M A; Henningfield J E; Cone E J
Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH)
Journal of analytical toxicology 1992;16(5):283-90.
-
1992: Huestis M A; Henningfield J E; Cone E J
Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
Journal of analytical toxicology 1992;16(5):276-82.
-
1992: Huestis M A; Sampson A H; Holicky B J; Henningfield J E; Cone E J
Characterization of the absorption phase of marijuana smoking.
Clinical pharmacology and therapeutics 1992;52(1):31-41.
-
1992: Higgins S T; Preston K L; Cone E J; Henningfield J E; Jaffe J H
Supersensitivity to naloxone following acute morphine pretreatment in humans: behavioral, hormonal and physiological effects.
Drug and alcohol dependence 1992;30(1):13-26.
-
1992: Mello N K; Lukas S E; Kamien J B; Mendelson J H; Drieze J; Cone E J
The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1992;260(3):1185-93.
-
1992: Cone E J; Dickerson S; Paul B D; Mitchell J M
Forensic drug testing for opiates. IV. Analytical sensitivity, specificity, and accuracy of commercial urine opiate immunoassays.
Journal of analytical toxicology 1992;16(2):72-8.
-
1992: Cone E J; Dickerson S L
Efficacy of urinalysis in monitoring heroin and cocaine abuse patterns: implications in clinical trials for treatment of drug dependence.
NIDA research monograph 1992;128():46-58; discussion 59-63.
-
1991: Su T P; Wu X Z; Cone E J; Shukla K; Gund T M; Dodge A L; Parish D W
Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand.
The Journal of pharmacology and experimental therapeutics 1991;259(2):543-50.
-
1991: Cone E J; Yousefnejad D; Darwin W D; Maguire T
Testing human hair for drugs of abuse. II. Identification of unique cocaine metabolites in hair of drug abusers and evaluation of decontamination procedures.
Journal of analytical toxicology 1991;15(5):250-5.
-
1991: Goldberger B A; Caplan Y H; Maguire T; Cone E J
Testing human hair for drugs of abuse. III. Identification of heroin and 6-acetylmorphine as indicators of heroin use.
Journal of analytical toxicology 1991;15(5):226-31.
-
1991: Cone E J; Welch P; Paul B D; Mitchell J M
Forensic drug testing for opiates, III. Urinary excretion rates of morphine and codeine following codeine administration.
Journal of analytical toxicology 1991;15(4):161-6.
-
1991: Mitchell J M; Paul B D; Welch P; Cone E J
Forensic drug testing for opiates. II. Metabolism and excretion rate of morphine in humans after morphine administration.
Journal of analytical toxicology 1991;15(2):49-53.
-
1991: Cone E J; Welch P; Mitchell J M; Paul B D
Forensic drug testing for opiates: I. Detection of 6-acetylmorphine in urine as an indicator of recent heroin exposure; drug and assay considerations and detection times.
Journal of analytical toxicology 1991;15(1):1-7.
-
1991: Vaupel D B; Cone E J
Pharmacodynamic and pharmacokinetic actions of ketocyclazocine enantiomers in the dog: absence of sigma- or phencyclidine-like activity.
The Journal of pharmacology and experimental therapeutics 1991;256(1):211-21.
-
1991: Pickworth W B; Bunker E; Welch P; Cone E
Intravenous buprenorphine reduces pupil size and the light reflex in humans.
Life sciences 1991;49(2):129-38.
-
1990: Heishman S J; Huestis M A; Henningfield J E; Cone E J
Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures.
Pharmacology, biochemistry, and behavior 1990;37(3):561-5.
-
1990: Weddington W W; Brown B S; Haertzen C A; Cone E J; Dax E M; Herning R I; Michaelson B S
Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study.
Archives of general psychiatry 1990;47(9):861-8.
-
1990: Furman W R; Munster A M; Cone E J
Morphine pharmacokinetics during anesthesia and surgery in patients with burns.
The Journal of burn care & rehabilitation 1990;11(5):391-4.
-
1990: Cone E J; Yousefnejad D; Dickerson S L
Validity testing of commercial urine cocaine metabolite assays: IV. Evaluation of the EMIT d.a.u. cocaine metabolite assay in a quantitative mode for detection of cocaine metabolite.
Journal of forensic sciences 1990;35(4):786-91.
-
1990: Kuhar M J; Boja J W; Cone E J
Phencyclidine binding to striatal cocaine receptors.
Neuropharmacology 1990;29(3):295-7.
-
1990: Lange W R; Cone E J; Snyder F R
The association of hepatitis delta virus and hepatitis B virus in parenteral drug abusers. 1971 to 1972 and 1986 to 1987.
Archives of internal medicine 1990;150(2):365-8.
-
1990: Cone E J
Testing human hair for drugs of abuse. I. Individual dose and time profiles of morphine and codeine in plasma, saliva, urine, and beard compared to drug-induced effects on pupils and behavior.
Journal of analytical toxicology 1990;14(1):1-7.
-
1990: Vaupel D B; Cone E J; Johnson R E; Su T P
Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
The Journal of pharmacology and experimental therapeutics 1990;252(1):225-34.
-
1990: Ritz M C; Cone E J; Kuhar M J
Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study.
Life sciences 1990;46(9):635-45.
-
1990: Cone E J
Marijuana effects and urinalysis after passive inhalation and oral ingestion.
NIDA research monograph 1990;99():88-96.
-
1990: Cone E J; Dickerson S L; Darwin W D; Fudala P; Johnson R E
Elevated drug saliva levels suggest a "depot-like" effect in subjects treated with sublingual buprenorphine.
NIDA research monograph 1990;105():569.
-
1990: Weddington W W; Brown B S; Cone E J; Haertzen C A; Dax E M; Herning R I; Michaelson B S
Changes in mood, craving and sleep during acute abstinence reported by male cocaine addicts.
NIDA research monograph 1990;105():453-4.
-
1989: Pickworth W B; Welch P; Henningfield J E; Cone E J
Opiate-induced pupillary effects in humans.
Methods and findings in experimental and clinical pharmacology 1989;11(12):759-63.
-
1989: Johnson R E; Cone E J; Henningfield J E; Fudala P J
Use of buprenorphine in the treatment of opiate addiction. I. Physiologic and behavioral effects during a rapid dose induction.
Clinical pharmacology and therapeutics 1989;46(3):335-43.
-
1989: Della Puppa A; Ford-Rice F; Snyder F R; Cone E; London E D
Time course of verapamil interaction with morphine effects on physiological parameters in rats.
The Journal of pharmacy and pharmacology 1989;41(9):617-23.
-
1989: Cone E J
Validity testing of commercial urine cocaine metabolite assays: III. Evaluation of an enzyme-linked immunosorbent assay (ELISA) for detection of cocaine and cocaine metabolite.
Journal of forensic sciences 1989;34(4):991-5.
-
1989: Lange W R; Ball J C; Pfeiffer M B; Snyder F R; Cone E J
The Lexington addicts, 1971-1972: demographic characteristics, drug use patterns, and selected infectious disease experience.
The International journal of the addictions 1989;24(7):609-26.
-
1989: Kumor K M; Sherer M A; Gomez J; Cone E; Jaffe J H
Subjective response during continuous infusion of cocaine.
Pharmacology, biochemistry, and behavior 1989;33(2):443-52.
-
1989: Cone E J; Weddington W W
Prolonged occurrence of cocaine in human saliva and urine after chronic use.
Journal of analytical toxicology 1989;13(2):65-8.
-
1989: Cone E J; Mitchell J
Validity testing of commercial urine cocaine metabolite assays: II. Sensitivity, specificity, accuracy, and confirmation by gas chromatography/mass spectrometry.
Journal of forensic sciences 1989;34(1):32-45.
-
1989: Cone E J; Menchen S L; Paul B D; Mell L D; Mitchell J
Validity testing of commercial urine cocaine metabolite assays: I. Assay detection times, individual excretion patterns, and kinetics after cocaine administration to humans.
Journal of forensic sciences 1989;34(1):15-31.
-
1989: Cone E J; Henningfield J E
Premier 'smokeless cigarettes' can be used to deliver crack.
JAMA : the journal of the American Medical Association 1989;261(1):41.
-
1989: Fudala P J; Johnson R E; Heishman S J; Cone E J; Henningfield J E
A dose run-up and safety evaluation of nalmefene HCl in human volunteers.
NIDA research monograph 1989;95():451-2.
-
1989: Cone E J; Welch P
Time course of detection of 6-acetylmorphine in urine after heroin administration.
NIDA research monograph 1989;95():449.
-
1988: Cone E J; Menchen S L
Stability of cocaine in saliva.
Clinical chemistry 1988;34(7):1508.
-
1988: Sherer M A; Kumor K M; Cone E J; Jaffe J H
Suspiciousness induced by four-hour intravenous infusions of cocaine. Preliminary findings.
Archives of general psychiatry 1988;45(7):673-7.
-
1988: Cone E J; Kumor K; Thompson L K; Sherer M
Correlation of saliva cocaine levels with plasma levels and with pharmacologic effects after intravenous cocaine administration in human subjects.
Journal of analytical toxicology 1988;12(4):200-6.
-
1988: Cone E J; Johnson R E; Paul B D; Mell L D; Mitchell J
Marijuana-laced brownies: behavioral effects, physiologic effects, and urinalysis in humans following ingestion.
Journal of analytical toxicology 1988;12(4):169-75.
-
1988: Cone E J; Menchen S L; Mitchell J
Validity testing of the TDx Cocaine Metabolite Assay with human specimens obtained after intravenous cocaine administration.
Forensic science international 1988;37(4):265-75.
-
1988: Jacob P; Benowitz N L; Copeland J R; Risner M E; Cone E J
Disposition kinetics of nicotine and cotinine enantiomers in rabbits and beagle dogs.
Journal of pharmaceutical sciences 1988;77(5):396-400.
-
1988: Risner M E; Cone E J; Benowitz N L; Jacob P
Effects of the stereoisomers of nicotine and nornicotine on schedule-controlled responding and physiological parameters of dogs.
The Journal of pharmacology and experimental therapeutics 1988;244(3):807-13.
-
1988: Cone E J; Welch P; Lange W R
Clonidine partially blocks the physiologic effects but not the subjective effects produced by smoking marijuana in male human subjects.
Pharmacology, biochemistry, and behavior 1988;29(3):649-52.
-
1988: Kumor K; Sherer M; Thompson L; Cone E; Mahaffey J; Jaffe J H
Lack of cardiovascular tolerance during intravenous cocaine infusions in human volunteers.
Life sciences 1988;42(21):2063-71.
-
1988: Higgins S; Preston K; Cone E; Henningfield J; Jaffe J
Behavioral, physiological and hormonal effects of a naloxone challenge following acute morphine pretreatment in humans.
NIDA research monograph 1988;81():202-8.
-
1987: Cone E J; Menchen S L
Lack of validity of the KDI Quik Test Drug Screen for detection of benzoylecgonine in urine.
Journal of analytical toxicology 1987;11(6):276-7.
-
1987: Thompson L K; Cone E J
Determination of delta 9-tetrahydrocannabinol in human blood and saliva by high-performance liquid chromatography with amperometric detection.
Journal of chromatography 1987;421(1):91-7.
-
1987: Cone E J; Johnson R E; Darwin W D; Yousefnejad D; Mell L D; Paul B D; Mitchell J
Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol.
Journal of analytical toxicology 1987;11(3):89-96.
-
1987: Thompson L K; Yousefnejad D; Kumor K; Sherer M; Cone E J
Confirmation of cocaine in human saliva after intravenous use.
Journal of analytical toxicology 1987;11(1):36-8.
-
1987: Cone E J; Roache J D; Johnson R E
Effects of passive exposure to marijuana smoke.
NIDA research monograph 1987;76():150-6.
-
1986: Cone E J; Yousefnejad D; Buchwald W D; Kumor K
Determination of ketocyclazocine in human plasma by gas chromatography-negative-ion chemical-ionization mass spectrometry.
Journal of chromatography 1986;383(1):158-65.
-
1986: Preston K L; Griffiths R R; Cone E J; Darwin W D; Gorodetzky C W
Diazepam and methadone blood levels following concurrent administration of diazepam and methadone.
Drug and alcohol dependence 1986;18(2):195-202.
-
1986: Cone E J; Johnson R E
Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke.
Clinical pharmacology and therapeutics 1986;40(3):247-56.
-
1986: Cone E J; Johnson R E; Moore J D; Roache J D
Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects.
Pharmacology, biochemistry, and behavior 1986;24(6):1749-54.
-
1986: Risner M E; Cone E J
Intravenous self-administration of fencamfamine and cocaine by beagle dogs under fixed-ratio and progressive-ratio schedules of reinforcement.
Drug and alcohol dependence 1986;17(1):93-102.
-
1986: Moore J D; Cone E J; Alexander S S
HTLV-III seropositivity in 1971-1972 parenteral drug abusers--a case of false positives for evidence of viral exposure?
The New England journal of medicine 1986;314(21):1387-8.
-
1985: Risner M E; Jackson-Smith P A; Cone E J
Discriminative stimulus properties and schedule effects of fencamfamine in rats.
Pharmacology, biochemistry, and behavior 1985;23(3):449-56.
-
1985: Risner M E; Goldberg S R; Prada J A; Cone E J
Effects of nicotine, cocaine and some of their metabolites on schedule-controlled responding by beagle dogs and squirrel monkeys.
The Journal of pharmacology and experimental therapeutics 1985;234(1):113-9.
-
1985: Cone E J; Gorodetzky C W; Yousefnejad D; Darwin W D
63Ni electron-capture gas chromatographic assay for buprenorphine and metabolites in human urine and feces.
Journal of chromatography 1985;337(2):291-300.
-
1984: Cone E J; Gorodetzky C W; Yousefnejad D; Buchwald W F; Johnson R E
The metabolism and excretion of buprenorphine in humans.
Drug metabolism and disposition: the biological fate of chemicals 1984;12(5):577-81.
-
1984: Vaupel D B; McCoun D; Cone E J
Phencyclidine analogs and precursors: rotarod and lethal dose studies in the mouse.
The Journal of pharmacology and experimental therapeutics 1984;230(1):20-7.
-
1984: Shannon H E; Cone E J; Gorodetzky C W
Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone.
The Journal of pharmacology and experimental therapeutics 1984;229(3):768-74.
-
1984: Gorodetzky C W; Cone E J; Johnson R E; Risner M E; Su T P; Yeh S Y
Progress report from the NIDA Addiction Research Center (preclinical laboratory), Lexington, Kentucky.
NIDA research monograph 1984;49():63-8.
-
1984: Cone E J; Gorodetzky C W; Darwin W D; Buchwald W F
Stability of the 6,14-endo-ethanotetrahydrooripavine analgesics: acid-catalyzed rearrangement of buprenorphine.
Journal of pharmaceutical sciences 1984;73(2):243-6.
-
1984: Cone E J; McQuinn R L; Shannon H E
Structure-activity relationship studies of phencyclidine derivatives in rats.
The Journal of pharmacology and experimental therapeutics 1984;228(1):147-53.
-
1984: Gorodetzky C W; Buchwald W F; Cone E J; Darwin W D; Pickworth W B; Risner M E; Sharpe L G
Progress report from the NIDA Addiction Research Center (preclinical laboratory), Lexington, Kentucky (1984).
NIDA research monograph 1984;55():52-8.
-
1983: Cone E J; Darwin W D; Buchwald W F; Gorodetzky C W
Oxymorphone metabolism and urinary excretion in human, rat, guinea pig, rabbit, and dog.
Drug metabolism and disposition: the biological fate of chemicals 1983;11(5):446-50.
-
1983: Cone E J; Darwin W D; Buchwald W F
Assay for codeine, morphine and ten potential urinary metabolites by gas chromatography--mass fragmentography.
Journal of chromatography 1983;275(2):307-18.
-
1983: Gorodetzky C W; Cone E J; Goldberg S R; Herling S; Risner M E; Shannon H E; Vaupel D B
Progress report from the NIDA Addiction Research Center (preclinical laboratory), Lexington, Kentucky.
NIDA research monograph 1983;43():85-91.
-
1983: Shannon H E; McQuinn R L; Vaupel D B; Cone E J
Effects of cycloalkyl ring analogs of phencyclidine on behavior in rodents.
The Journal of pharmacology and experimental therapeutics 1983;224(2):327-33.
-
1982: Cone E J; Buchwald W F; Darwin W D
Analytical controls in drug metabolic studies. II. Artifact formation during chloroform extraction of drugs and metabolites with amine substituents.
Drug metabolism and disposition: the biological fate of chemicals 1982;10(6):561-7.
-
1982: Shannon H E; Cone E J; Yousefnejad D
Physiologic effects and plasma kinetics of beta-phenylethylamine and its N-methyl homolog in the dog.
The Journal of pharmacology and experimental therapeutics 1982;223(1):190-6.
-
1982: Cone E J; Gorodetzky C W; Yeh S Y; Darwin W D; Buchwald W F
Detection and measurement of opium alkaloids and metabolites in urine of opium eaters by methane chemical ionization mass fragmentography.
Journal of chromatography 1982;230(1):57-67.
-
1982: Gorodetzky C W; Cone E J; Croughan J L; Goldberg S R; Risner M E; Shannon H E; Su T P; Yeh S Y
Progress report from the NIDA Addiction Research Center (Preclinical Laboratory), Lexington, Ky.
NIDA research monograph 1982;41():53-9.
-
1982: Cone E; Shannon H; Vaupel B; Su T P; McQuinn R
A structure activity relationship study of the cyclohexyl and aromatic rings of phencyclidine (PCP).
NIDA research monograph 1982;41():126-33.
-
1982: Cone E J; Vaupel D B; Yousefnejad D
Monohydroxymetabolites of phencyclidine (PCP): activities and urinary excretion by rat, dog and mouse.
The Journal of pharmacy and pharmacology 1982;34(3):197-9.
-
1981: McQuinn R L; Cone E J; Shannon H E; Su T P
Structure-activity relationships of the cycloalkyl ring of phencyclidine.
Journal of medicinal chemistry 1981;24(12):1429-32.
-
1981: Carroll F I; Brine G A; Boldt K G; Cone E J; Yousefnejad D; Vaupel D B; Buchwald W F
Phencyclidine metabolism: resolution, structure, and biological activity of the isomers of the hydroxy metabolite, 4-phenyl-4-(1-piperidinyl)cyclohexanol.
Journal of medicinal chemistry 1981;24(9):1047-51.
-
1981: Cone E J; Buchwald W; Yousefnejad D
Simultaneous determination of phencyclidine and monohydroxylated metabolites in urine of man by gas chromatography-mass fragmentography with methane chemical ionization.
Journal of chromatography 1981;223(2):331-9.
-
1981: Shannon H E; Cone E J; Yousefnejad D
Physiologic effects and plasma kinetics of phenylethanolamine and its N-methyl homolog in the dog.
The Journal of pharmacology and experimental therapeutics 1981;217(2):379-85.
-
1981: Vaupel D B; Cone E J
A pharmacologic comparison between phencyclidine, its precursor, metabolites, and a quaternary derivative in the dog.
NIDA research monograph 1981;34():180-6.
-
1980: Jasinski D R; Shannon H E; Vaupel D B; Cone E J; Risner M E; McQuinn R L; Su T P; Pickworth W B
Interdisciplinary studies on phencyclidine at the Addiction Research Center, Lexington, Kentucky [proceedings]
Psychopharmacology bulletin 1980;16(4):79-81.
-
1980: Cone E J; Vaupel D B; Buchwald W F
Phencyclidine: Detection and measurement of toxic precursors and analogs in lllicit samples.
Journal of analytical toxicology 1980;4(3):119-23.
-
1980: Darwin W D; Cone E J
Fluorescence properties of pseudomorphine and congeners: structure-activity relationships.
Journal of pharmaceutical sciences 1980;69(3):253-7.
-
1980: Shannon H E; Vaupel D B; Risner M E; Cone E J
Pharmacology of phenethylamine trace amines in the dog--discussion.
Psychopharmacology bulletin 1980;16(1):54-5.
-
1979: Cone E J; Darwin W D; Yousefnejad D; Buchwald W F
Separation and identification of phencyclidine precursors, metabolites and analogs by gas and thin-layer chromatography and chemical ionization mass spectrometry.
Journal of chromatography 1979;177(1):149-53.
-
1979: Cone E J; Darwin W D; Gorodetzky C W
Comparative metabolism of codeine in man, rat, dog, guinea-pig and rabbit: identification of four new metabolites.
The Journal of pharmacy and pharmacology 1979;31(5):314-7.
-
1979: Jasinski D R; Cone E J; Gorodetzky C W; Risner M E; Shannon H E; Su T P; Vaupel D B
Progress report from the NIDA Addiction Research Center.
NIDA research monograph 1979;27():61-9.
-
1978: Cone E J; Risner M E; Neidert G L
Concentrations of phenethylamine in dog following single doses and during intravenous self-administration.
Research communications in chemical pathology and pharmacology 1978;22(2):211-32.
-
1978: Cone E J; Darwin W D; Gorodetzky C W; Tan T
Comparative metabolism of hydrocodone in man, rat, guinea pig, rabbit, and dog.
Drug metabolism and disposition: the biological fate of chemicals 1978;6(4):488-93.
-
1978: Cone E J; Gorodetzky C W; Darwin W D; Carroll F I; Brine G A; Welch C D
The identification and measurement of two new metabolites of naltrexone in human urine.
Research communications in chemical pathology and pharmacology 1978;20(3):413-33.
-
1978: Cone E J
The metabolism of azidomorphine in a human subject.
Xenobiotica; the fate of foreign compounds in biological systems 1978;8(5):301-4.
-
1978: Cone E J; Darwin W D
Simultaneous determination of hydromorphone, hydrocodone and their 6alpha- and 6beta-hydroxy metabolites in urine using selected ion recording with methane chemical ionization.
Biomedical mass spectrometry 1978;5(4):291.
-
1977: Cone E J; Phelps B A; Gorodetzky C W
Urinary excretion of hydromorphone and metabolites in humans, rats, dogs, guinea pigs, and rabbits.
Journal of pharmaceutical sciences 1977;66(12):1709-13.
-
1976: Cone E J
General procedure for the isolation and identification of 6-alpha- and 6-beta-hydroxy metabolites of narcotic agonists and antagonists with a hydromorphone structure.
Journal of chromatography 1976;129():355-61.
-
1975: Cone E J; Gorodetzky C W
Analytical controls in drug metabolic studies. A commentary.
Drug metabolism and disposition: the biological fate of chemicals 1975;3(5):417-8.
-
1975: Cone E J; Gorodetzky C W; Yeh S Y
Biosynthesis, isolation, and identification of 6-beta-hydroxynaltrexone, a major human metabolite of naltrexone.
Journal of pharmaceutical sciences 1975;64(4):618-21.
-
1974: Cone E J; Gorodetzky C W; Yeh S Y
The urinary excretion profile of naltrexone and metabolites in man.
Drug metabolism and disposition: the biological fate of chemicals 1974;2(6):506-12.
Sign-in to see more
